Tuesday 12 March 2013

Inspection of speciality compounding pharmacies

Following the fungal meningitis outbreak last fall that was linked to contaminated sterile drugs (NECC), the FDA has launched an inspection campaign of large specialty pharmacies. The inspections mid February and will continue over the next two months, covering about 30 facilities.

For further information see: Washington Post

Posted by Tim Sandle

1 comment:

  1. note that the pharma industry lobbied to prevent federal regulation of the growing compounding-pharmacy industry, and thereafter the worst happened -


Pharmaceutical Microbiology Resources

Special offers